Targeting Vector, Nucleic Acid Composition, and Method for Constructing Liver-injured Mouse Model
AssigneeGempharmatech Co., Ltd.
InventorsCunxiang JU, Dongjing JIA, Jing ZHAO
Life of this patent
Estimating the term…
Loading patent…
AssigneeGempharmatech Co., Ltd.
InventorsCunxiang JU, Dongjing JIA, Jing ZHAO
Estimating the term…
Provided are a targeting vector, a nucleic acid composition, and a method for constructing a liver-injured mouse model. The targeting vector includes a first expression cassette and a second expression cassette located downstream of the first expression cassette, the first expression cassette has the following elements connected in series in sequence: a liver-specific promoter, a tetracycline transcription activation regulating factor, and a first polyA; and the second expression cassette has the following elements connected in series in sequence: a second polyA, a mouse prourokinase activator encoding gene, and a tetracycline-inducible promoter. The liver-injured mouse model constructed with this targeting vector has the phenotype of spontaneously generating the liver injury and aggravating the liver injury by induction, which provides liver-injured mouse models for studies of liver diseases.
A targeting vector for constructing a liver-injured mouse model, wherein the targeting vector contains a target sequence, and a 5′ end homologous arm sequence and a 3′ end homologous arm sequence for mediating insertion of the target sequence into a target site in a mouse genome, wherein the target sequence comprises a first expression cassette and a second expression cassette located downstream of the first expression cassette,
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.